Datasheet | August 11, 2022

The Way Forward In Antibody Therapeutics Purification

We have developed an innovative portfolio of affinity chromatography resins to support you in the downstream process of next-generation antibody therapeutics. These resins are specifically designed for the purification of monoclonal antibodies (mAbs) and engineered antibody modalities such as Fab fragments, bi-specific antibodies and Fc-fusion proteins.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online